Evaluation of [ 18 F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy

Sanni Tuominen, Thomas Keller, Natalia Petruk, Francisco López-Picón, Dominik Eichin, Eliisa Löyttyniemi, Alejandra Verhassel , Johan Rajander, Jouko Sandholm , Johanna Tuomela, Tove J Grönroos

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Sammanfattning

Many malignant tumours have increased TSPO expression, which has been related to a poor prognosis. TSPO-PET tracers have not comprehensively been evaluated in peripherally located tumours. This study aimed to evaluate whether N,N-diethyl-2-(2-(4-([18F]fluoro)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide ([18F]F-DPA) can reflect radiotherapy (RT)-induced changes in TSPO activity in head and neck squamous cell carcinoma (HNSCC).
OriginalspråkEngelska
TidskriftEuropean Journal of Nuclear Medicine and Molecular Imaging
DOI
StatusPublicerad - 19 dec 2020
MoE-publikationstypA1 Tidskriftsartikel-refererad

Fingeravtryck Fördjupa i forskningsämnen för ”Evaluation of [ 18 F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här